nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—ABCB1—ovarian cancer	0.48	1	CbGaD
Nitrazepam—ABCB1—Topotecan—ovarian cancer	0.0461	0.221	CbGbCtD
Nitrazepam—ABCB1—Vinorelbine—ovarian cancer	0.0325	0.156	CbGbCtD
Nitrazepam—CYP3A4—Topotecan—ovarian cancer	0.0276	0.133	CbGbCtD
Nitrazepam—ABCB1—Paclitaxel—ovarian cancer	0.0228	0.11	CbGbCtD
Nitrazepam—CYP3A4—Vinorelbine—ovarian cancer	0.0195	0.0935	CbGbCtD
Nitrazepam—ABCB1—Docetaxel—ovarian cancer	0.0165	0.0792	CbGbCtD
Nitrazepam—CYP3A4—Paclitaxel—ovarian cancer	0.0137	0.0657	CbGbCtD
Nitrazepam—ABCB1—Doxorubicin—ovarian cancer	0.0123	0.0591	CbGbCtD
Nitrazepam—CYP3A4—Docetaxel—ovarian cancer	0.00989	0.0475	CbGbCtD
Nitrazepam—CYP3A4—Doxorubicin—ovarian cancer	0.00737	0.0354	CbGbCtD
Nitrazepam—GABRP—uterine cervix—ovarian cancer	0.00148	0.0451	CbGeAlD
Nitrazepam—GABRE—myometrium—ovarian cancer	0.00145	0.0442	CbGeAlD
Nitrazepam—GABRP—decidua—ovarian cancer	0.00141	0.043	CbGeAlD
Nitrazepam—GABRP—endometrium—ovarian cancer	0.00134	0.0408	CbGeAlD
Nitrazepam—GABRG3—testis—ovarian cancer	0.00129	0.0394	CbGeAlD
Nitrazepam—GABRP—uterus—ovarian cancer	0.00123	0.0376	CbGeAlD
Nitrazepam—GABRR1—testis—ovarian cancer	0.00123	0.0375	CbGeAlD
Nitrazepam—GABRE—uterine cervix—ovarian cancer	0.00113	0.0344	CbGeAlD
Nitrazepam—GABRB1—vagina—ovarian cancer	0.00112	0.0341	CbGeAlD
Nitrazepam—GABRP—female reproductive system—ovarian cancer	0.00111	0.0338	CbGeAlD
Nitrazepam—GABRE—decidua—ovarian cancer	0.00108	0.0328	CbGeAlD
Nitrazepam—GABRD—testis—ovarian cancer	0.00107	0.0326	CbGeAlD
Nitrazepam—GABRE—endometrium—ovarian cancer	0.00102	0.0311	CbGeAlD
Nitrazepam—Lethargy—Docetaxel—ovarian cancer	0.001	0.00401	CcSEcCtD
Nitrazepam—GABRP—vagina—ovarian cancer	0.001	0.0306	CbGeAlD
Nitrazepam—Dysphagia—Paclitaxel—ovarian cancer	0.001	0.00401	CcSEcCtD
Nitrazepam—Thinking abnormal—Epirubicin—ovarian cancer	0.000999	0.00399	CcSEcCtD
Nitrazepam—GABRA5—testis—ovarian cancer	0.000995	0.0303	CbGeAlD
Nitrazepam—Infection—Topotecan—ovarian cancer	0.000985	0.00394	CcSEcCtD
Nitrazepam—Dyspepsia—Chlorambucil—ovarian cancer	0.00098	0.00392	CcSEcCtD
Nitrazepam—Dysarthria—Epirubicin—ovarian cancer	0.000967	0.00386	CcSEcCtD
Nitrazepam—Infection—Melphalan—ovarian cancer	0.000965	0.00385	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000962	0.00384	CcSEcCtD
Nitrazepam—Fatigue—Chlorambucil—ovarian cancer	0.00096	0.00384	CcSEcCtD
Nitrazepam—Hyperhidrosis—Topotecan—ovarian cancer	0.000959	0.00383	CcSEcCtD
Nitrazepam—Malaise—Vinorelbine—ovarian cancer	0.000937	0.00374	CcSEcCtD
Nitrazepam—Gait disturbance—Epirubicin—ovarian cancer	0.000937	0.00374	CcSEcCtD
Nitrazepam—Vertigo—Vinorelbine—ovarian cancer	0.000934	0.00373	CcSEcCtD
Nitrazepam—Coordination abnormal—Epirubicin—ovarian cancer	0.000931	0.00372	CcSEcCtD
Nitrazepam—Leukopenia—Vinorelbine—ovarian cancer	0.00093	0.00372	CcSEcCtD
Nitrazepam—GABRR2—lymph node—ovarian cancer	0.000928	0.0283	CbGeAlD
Nitrazepam—GABRA3—testis—ovarian cancer	0.000926	0.0282	CbGeAlD
Nitrazepam—Ataxia—Docetaxel—ovarian cancer	0.000925	0.0037	CcSEcCtD
Nitrazepam—Thinking abnormal—Doxorubicin—ovarian cancer	0.000924	0.00369	CcSEcCtD
Nitrazepam—Palpitations—Vinorelbine—ovarian cancer	0.000918	0.00367	CcSEcCtD
Nitrazepam—Feeling abnormal—Chlorambucil—ovarian cancer	0.000918	0.00367	CcSEcCtD
Nitrazepam—Hypotension—Melphalan—ovarian cancer	0.000907	0.00362	CcSEcCtD
Nitrazepam—Abnormal dreams—Epirubicin—ovarian cancer	0.000903	0.00361	CcSEcCtD
Nitrazepam—Pneumonia—Paclitaxel—ovarian cancer	0.0009	0.00359	CcSEcCtD
Nitrazepam—Dysarthria—Doxorubicin—ovarian cancer	0.000894	0.00357	CcSEcCtD
Nitrazepam—Paraesthesia—Topotecan—ovarian cancer	0.00089	0.00356	CcSEcCtD
Nitrazepam—Salivary hypersecretion—Epirubicin—ovarian cancer	0.000888	0.00355	CcSEcCtD
Nitrazepam—Cramp muscle—Docetaxel—ovarian cancer	0.000886	0.00354	CcSEcCtD
Nitrazepam—Dyspnoea—Topotecan—ovarian cancer	0.000884	0.00353	CcSEcCtD
Nitrazepam—Dyspepsia—Topotecan—ovarian cancer	0.000873	0.00349	CcSEcCtD
Nitrazepam—Paraesthesia—Melphalan—ovarian cancer	0.000872	0.00348	CcSEcCtD
Nitrazepam—Gait disturbance—Doxorubicin—ovarian cancer	0.000867	0.00346	CcSEcCtD
Nitrazepam—Dyspnoea—Melphalan—ovarian cancer	0.000866	0.00346	CcSEcCtD
Nitrazepam—Coordination abnormal—Doxorubicin—ovarian cancer	0.000861	0.00344	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000856	0.00342	CcSEcCtD
Nitrazepam—Fatigue—Topotecan—ovarian cancer	0.000855	0.00342	CcSEcCtD
Nitrazepam—Dyspepsia—Melphalan—ovarian cancer	0.000855	0.00341	CcSEcCtD
Nitrazepam—Dysphagia—Docetaxel—ovarian cancer	0.00085	0.0034	CcSEcCtD
Nitrazepam—Constipation—Topotecan—ovarian cancer	0.000848	0.00339	CcSEcCtD
Nitrazepam—GABRE—female reproductive system—ovarian cancer	0.000847	0.0258	CbGeAlD
Nitrazepam—Infection—Vinorelbine—ovarian cancer	0.000843	0.00337	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000838	0.00335	CcSEcCtD
Nitrazepam—Fatigue—Melphalan—ovarian cancer	0.000837	0.00334	CcSEcCtD
Nitrazepam—Abnormal dreams—Doxorubicin—ovarian cancer	0.000836	0.00334	CcSEcCtD
Nitrazepam—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000822	0.00328	CcSEcCtD
Nitrazepam—Hypersensitivity—Chlorambucil—ovarian cancer	0.000821	0.00328	CcSEcCtD
Nitrazepam—Feeling abnormal—Topotecan—ovarian cancer	0.000817	0.00326	CcSEcCtD
Nitrazepam—GABRB3—gonad—ovarian cancer	0.000804	0.0245	CbGeAlD
Nitrazepam—Asthenia—Chlorambucil—ovarian cancer	0.000799	0.00319	CcSEcCtD
Nitrazepam—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000799	0.00319	CcSEcCtD
Nitrazepam—Mental disability—Epirubicin—ovarian cancer	0.000793	0.00317	CcSEcCtD
Nitrazepam—Hypotension—Vinorelbine—ovarian cancer	0.000793	0.00317	CcSEcCtD
Nitrazepam—Pruritus—Chlorambucil—ovarian cancer	0.000788	0.00315	CcSEcCtD
Nitrazepam—GABRA2—vagina—ovarian cancer	0.000773	0.0235	CbGeAlD
Nitrazepam—GABRE—female gonad—ovarian cancer	0.000771	0.0235	CbGeAlD
Nitrazepam—GABRE—vagina—ovarian cancer	0.000766	0.0233	CbGeAlD
Nitrazepam—Pneumonia—Docetaxel—ovarian cancer	0.000763	0.00305	CcSEcCtD
Nitrazepam—Diarrhoea—Chlorambucil—ovarian cancer	0.000762	0.00304	CcSEcCtD
Nitrazepam—Paraesthesia—Vinorelbine—ovarian cancer	0.000762	0.00304	CcSEcCtD
Nitrazepam—Dyspnoea—Vinorelbine—ovarian cancer	0.000756	0.00302	CcSEcCtD
Nitrazepam—GABRB2—testis—ovarian cancer	0.000755	0.023	CbGeAlD
Nitrazepam—Jaundice—Docetaxel—ovarian cancer	0.000739	0.00295	CcSEcCtD
Nitrazepam—Mental disability—Doxorubicin—ovarian cancer	0.000734	0.00293	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000732	0.00293	CcSEcCtD
Nitrazepam—Fatigue—Vinorelbine—ovarian cancer	0.000731	0.00292	CcSEcCtD
Nitrazepam—Hypersensitivity—Topotecan—ovarian cancer	0.000731	0.00292	CcSEcCtD
Nitrazepam—Constipation—Vinorelbine—ovarian cancer	0.000725	0.0029	CcSEcCtD
Nitrazepam—GABRB3—female reproductive system—ovarian cancer	0.000718	0.0219	CbGeAlD
Nitrazepam—Hypersensitivity—Melphalan—ovarian cancer	0.000715	0.00286	CcSEcCtD
Nitrazepam—Asthenia—Topotecan—ovarian cancer	0.000711	0.00284	CcSEcCtD
Nitrazepam—Vomiting—Chlorambucil—ovarian cancer	0.000708	0.00283	CcSEcCtD
Nitrazepam—Agranulocytosis—Docetaxel—ovarian cancer	0.000708	0.00283	CcSEcCtD
Nitrazepam—Pruritus—Topotecan—ovarian cancer	0.000702	0.0028	CcSEcCtD
Nitrazepam—Feeling abnormal—Vinorelbine—ovarian cancer	0.000699	0.00279	CcSEcCtD
Nitrazepam—Asthenia—Melphalan—ovarian cancer	0.000697	0.00278	CcSEcCtD
Nitrazepam—Pruritus—Melphalan—ovarian cancer	0.000687	0.00274	CcSEcCtD
Nitrazepam—Tension—Paclitaxel—ovarian cancer	0.000686	0.00274	CcSEcCtD
Nitrazepam—GABRE—testis—ovarian cancer	0.000684	0.0208	CbGeAlD
Nitrazepam—Nervousness—Paclitaxel—ovarian cancer	0.000679	0.00271	CcSEcCtD
Nitrazepam—Diarrhoea—Topotecan—ovarian cancer	0.000678	0.00271	CcSEcCtD
Nitrazepam—Hypoaesthesia—Docetaxel—ovarian cancer	0.000677	0.00271	CcSEcCtD
Nitrazepam—Lethargy—Epirubicin—ovarian cancer	0.000677	0.00271	CcSEcCtD
Nitrazepam—Muscle spasms—Paclitaxel—ovarian cancer	0.000672	0.00268	CcSEcCtD
Nitrazepam—Diarrhoea—Melphalan—ovarian cancer	0.000664	0.00265	CcSEcCtD
Nitrazepam—Diplopia—Epirubicin—ovarian cancer	0.000664	0.00265	CcSEcCtD
Nitrazepam—Nausea—Chlorambucil—ovarian cancer	0.000662	0.00264	CcSEcCtD
Nitrazepam—Vision blurred—Paclitaxel—ovarian cancer	0.000659	0.00263	CcSEcCtD
Nitrazepam—Dizziness—Topotecan—ovarian cancer	0.000656	0.00262	CcSEcCtD
Nitrazepam—Tremor—Paclitaxel—ovarian cancer	0.000655	0.00262	CcSEcCtD
Nitrazepam—Agitation—Paclitaxel—ovarian cancer	0.000642	0.00257	CcSEcCtD
Nitrazepam—Vomiting—Topotecan—ovarian cancer	0.00063	0.00252	CcSEcCtD
Nitrazepam—Malaise—Paclitaxel—ovarian cancer	0.00063	0.00252	CcSEcCtD
Nitrazepam—Vertigo—Paclitaxel—ovarian cancer	0.000628	0.00251	CcSEcCtD
Nitrazepam—Syncope—Paclitaxel—ovarian cancer	0.000627	0.0025	CcSEcCtD
Nitrazepam—Lethargy—Doxorubicin—ovarian cancer	0.000627	0.0025	CcSEcCtD
Nitrazepam—Leukopenia—Paclitaxel—ovarian cancer	0.000626	0.0025	CcSEcCtD
Nitrazepam—Rash—Topotecan—ovarian cancer	0.000625	0.0025	CcSEcCtD
Nitrazepam—Hypersensitivity—Vinorelbine—ovarian cancer	0.000625	0.0025	CcSEcCtD
Nitrazepam—Dermatitis—Topotecan—ovarian cancer	0.000625	0.0025	CcSEcCtD
Nitrazepam—Ataxia—Epirubicin—ovarian cancer	0.000624	0.00249	CcSEcCtD
Nitrazepam—Headache—Topotecan—ovarian cancer	0.000621	0.00248	CcSEcCtD
Nitrazepam—Palpitations—Paclitaxel—ovarian cancer	0.000618	0.00247	CcSEcCtD
Nitrazepam—Vomiting—Melphalan—ovarian cancer	0.000617	0.00247	CcSEcCtD
Nitrazepam—Loss of consciousness—Paclitaxel—ovarian cancer	0.000614	0.00245	CcSEcCtD
Nitrazepam—Diplopia—Doxorubicin—ovarian cancer	0.000614	0.00245	CcSEcCtD
Nitrazepam—Rash—Melphalan—ovarian cancer	0.000612	0.00245	CcSEcCtD
Nitrazepam—Dermatitis—Melphalan—ovarian cancer	0.000612	0.00244	CcSEcCtD
Nitrazepam—Asthenia—Vinorelbine—ovarian cancer	0.000609	0.00243	CcSEcCtD
Nitrazepam—Convulsion—Paclitaxel—ovarian cancer	0.000606	0.00242	CcSEcCtD
Nitrazepam—Pruritus—Vinorelbine—ovarian cancer	0.0006	0.0024	CcSEcCtD
Nitrazepam—Anxiety—Paclitaxel—ovarian cancer	0.000593	0.00237	CcSEcCtD
Nitrazepam—Nausea—Topotecan—ovarian cancer	0.000589	0.00235	CcSEcCtD
Nitrazepam—Muscular weakness—Epirubicin—ovarian cancer	0.000585	0.00234	CcSEcCtD
Nitrazepam—Diarrhoea—Vinorelbine—ovarian cancer	0.00058	0.00232	CcSEcCtD
Nitrazepam—GABRB3—testis—ovarian cancer	0.00058	0.0176	CbGeAlD
Nitrazepam—Ataxia—Doxorubicin—ovarian cancer	0.000577	0.00231	CcSEcCtD
Nitrazepam—Nausea—Melphalan—ovarian cancer	0.000577	0.0023	CcSEcCtD
Nitrazepam—Confusional state—Paclitaxel—ovarian cancer	0.000575	0.0023	CcSEcCtD
Nitrazepam—Dysphagia—Epirubicin—ovarian cancer	0.000574	0.00229	CcSEcCtD
Nitrazepam—Muscle spasms—Docetaxel—ovarian cancer	0.00057	0.00228	CcSEcCtD
Nitrazepam—Infection—Paclitaxel—ovarian cancer	0.000567	0.00226	CcSEcCtD
Nitrazepam—Shock—Paclitaxel—ovarian cancer	0.000561	0.00224	CcSEcCtD
Nitrazepam—Dizziness—Vinorelbine—ovarian cancer	0.000561	0.00224	CcSEcCtD
Nitrazepam—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000552	0.0022	CcSEcCtD
Nitrazepam—Muscular weakness—Doxorubicin—ovarian cancer	0.000542	0.00216	CcSEcCtD
Nitrazepam—Vomiting—Vinorelbine—ovarian cancer	0.000539	0.00215	CcSEcCtD
Nitrazepam—Rash—Vinorelbine—ovarian cancer	0.000535	0.00214	CcSEcCtD
Nitrazepam—Dermatitis—Vinorelbine—ovarian cancer	0.000534	0.00213	CcSEcCtD
Nitrazepam—Hypotension—Paclitaxel—ovarian cancer	0.000533	0.00213	CcSEcCtD
Nitrazepam—Headache—Vinorelbine—ovarian cancer	0.000531	0.00212	CcSEcCtD
Nitrazepam—Syncope—Docetaxel—ovarian cancer	0.000531	0.00212	CcSEcCtD
Nitrazepam—Dysphagia—Doxorubicin—ovarian cancer	0.000531	0.00212	CcSEcCtD
Nitrazepam—Leukopenia—Docetaxel—ovarian cancer	0.00053	0.00212	CcSEcCtD
Nitrazepam—Palpitations—Docetaxel—ovarian cancer	0.000524	0.00209	CcSEcCtD
Nitrazepam—Loss of consciousness—Docetaxel—ovarian cancer	0.000521	0.00208	CcSEcCtD
Nitrazepam—Pneumonia—Epirubicin—ovarian cancer	0.000514	0.00205	CcSEcCtD
Nitrazepam—Convulsion—Docetaxel—ovarian cancer	0.000513	0.00205	CcSEcCtD
Nitrazepam—Paraesthesia—Paclitaxel—ovarian cancer	0.000512	0.00205	CcSEcCtD
Nitrazepam—Drowsiness—Epirubicin—ovarian cancer	0.000511	0.00204	CcSEcCtD
Nitrazepam—Dyspnoea—Paclitaxel—ovarian cancer	0.000509	0.00203	CcSEcCtD
Nitrazepam—Somnolence—Paclitaxel—ovarian cancer	0.000507	0.00203	CcSEcCtD
Nitrazepam—Nausea—Vinorelbine—ovarian cancer	0.000504	0.00201	CcSEcCtD
Nitrazepam—Dyspepsia—Paclitaxel—ovarian cancer	0.000502	0.00201	CcSEcCtD
Nitrazepam—GABRA2—lymph node—ovarian cancer	0.0005	0.0152	CbGeAlD
Nitrazepam—Jaundice—Epirubicin—ovarian cancer	0.000498	0.00199	CcSEcCtD
Nitrazepam—GABRE—lymph node—ovarian cancer	0.000496	0.0151	CbGeAlD
Nitrazepam—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000493	0.00197	CcSEcCtD
Nitrazepam—Fatigue—Paclitaxel—ovarian cancer	0.000492	0.00196	CcSEcCtD
Nitrazepam—Sweating—Epirubicin—ovarian cancer	0.00049	0.00196	CcSEcCtD
Nitrazepam—Constipation—Paclitaxel—ovarian cancer	0.000488	0.00195	CcSEcCtD
Nitrazepam—Confusional state—Docetaxel—ovarian cancer	0.000488	0.00195	CcSEcCtD
Nitrazepam—Infection—Docetaxel—ovarian cancer	0.00048	0.00192	CcSEcCtD
Nitrazepam—Agranulocytosis—Epirubicin—ovarian cancer	0.000477	0.00191	CcSEcCtD
Nitrazepam—Pneumonia—Doxorubicin—ovarian cancer	0.000476	0.0019	CcSEcCtD
Nitrazepam—Shock—Docetaxel—ovarian cancer	0.000476	0.0019	CcSEcCtD
Nitrazepam—Drowsiness—Doxorubicin—ovarian cancer	0.000473	0.00189	CcSEcCtD
Nitrazepam—Feeling abnormal—Paclitaxel—ovarian cancer	0.00047	0.00188	CcSEcCtD
Nitrazepam—Jaundice—Doxorubicin—ovarian cancer	0.000461	0.00184	CcSEcCtD
Nitrazepam—CYP2E1—female reproductive system—ovarian cancer	0.000457	0.0139	CbGeAlD
Nitrazepam—Hypoaesthesia—Epirubicin—ovarian cancer	0.000457	0.00182	CcSEcCtD
Nitrazepam—Sweating—Doxorubicin—ovarian cancer	0.000454	0.00181	CcSEcCtD
Nitrazepam—Hypotension—Docetaxel—ovarian cancer	0.000452	0.00181	CcSEcCtD
Nitrazepam—ABCB1—myometrium—ovarian cancer	0.000446	0.0136	CbGeAlD
Nitrazepam—Agranulocytosis—Doxorubicin—ovarian cancer	0.000442	0.00176	CcSEcCtD
Nitrazepam—Paraesthesia—Docetaxel—ovarian cancer	0.000434	0.00173	CcSEcCtD
Nitrazepam—Dyspnoea—Docetaxel—ovarian cancer	0.000431	0.00172	CcSEcCtD
Nitrazepam—Somnolence—Docetaxel—ovarian cancer	0.00043	0.00172	CcSEcCtD
Nitrazepam—ABCB1—embryo—ovarian cancer	0.000429	0.0131	CbGeAlD
Nitrazepam—Dyspepsia—Docetaxel—ovarian cancer	0.000426	0.0017	CcSEcCtD
Nitrazepam—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000423	0.00169	CcSEcCtD
Nitrazepam—Hypersensitivity—Paclitaxel—ovarian cancer	0.00042	0.00168	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000417	0.00167	CcSEcCtD
Nitrazepam—Fatigue—Docetaxel—ovarian cancer	0.000417	0.00167	CcSEcCtD
Nitrazepam—Constipation—Docetaxel—ovarian cancer	0.000414	0.00165	CcSEcCtD
Nitrazepam—Asthenia—Paclitaxel—ovarian cancer	0.000409	0.00164	CcSEcCtD
Nitrazepam—Pruritus—Paclitaxel—ovarian cancer	0.000404	0.00161	CcSEcCtD
Nitrazepam—Feeling abnormal—Docetaxel—ovarian cancer	0.000398	0.00159	CcSEcCtD
Nitrazepam—Tension—Epirubicin—ovarian cancer	0.000392	0.00157	CcSEcCtD
Nitrazepam—Diarrhoea—Paclitaxel—ovarian cancer	0.00039	0.00156	CcSEcCtD
Nitrazepam—Nervousness—Epirubicin—ovarian cancer	0.000388	0.00155	CcSEcCtD
Nitrazepam—Muscle spasms—Epirubicin—ovarian cancer	0.000384	0.00153	CcSEcCtD
Nitrazepam—Dizziness—Paclitaxel—ovarian cancer	0.000377	0.00151	CcSEcCtD
Nitrazepam—Vision blurred—Epirubicin—ovarian cancer	0.000377	0.0015	CcSEcCtD
Nitrazepam—CYP2E1—testis—ovarian cancer	0.000369	0.0112	CbGeAlD
Nitrazepam—CYP3A4—female reproductive system—ovarian cancer	0.000368	0.0112	CbGeAlD
Nitrazepam—Agitation—Epirubicin—ovarian cancer	0.000367	0.00147	CcSEcCtD
Nitrazepam—Tension—Doxorubicin—ovarian cancer	0.000363	0.00145	CcSEcCtD
Nitrazepam—Vomiting—Paclitaxel—ovarian cancer	0.000363	0.00145	CcSEcCtD
Nitrazepam—Malaise—Epirubicin—ovarian cancer	0.00036	0.00144	CcSEcCtD
Nitrazepam—Rash—Paclitaxel—ovarian cancer	0.00036	0.00144	CcSEcCtD
Nitrazepam—Dermatitis—Paclitaxel—ovarian cancer	0.000359	0.00144	CcSEcCtD
Nitrazepam—Nervousness—Doxorubicin—ovarian cancer	0.000359	0.00143	CcSEcCtD
Nitrazepam—Vertigo—Epirubicin—ovarian cancer	0.000359	0.00143	CcSEcCtD
Nitrazepam—Syncope—Epirubicin—ovarian cancer	0.000358	0.00143	CcSEcCtD
Nitrazepam—Leukopenia—Epirubicin—ovarian cancer	0.000358	0.00143	CcSEcCtD
Nitrazepam—Headache—Paclitaxel—ovarian cancer	0.000357	0.00143	CcSEcCtD
Nitrazepam—Hypersensitivity—Docetaxel—ovarian cancer	0.000356	0.00142	CcSEcCtD
Nitrazepam—Muscle spasms—Doxorubicin—ovarian cancer	0.000356	0.00142	CcSEcCtD
Nitrazepam—Palpitations—Epirubicin—ovarian cancer	0.000353	0.00141	CcSEcCtD
Nitrazepam—Loss of consciousness—Epirubicin—ovarian cancer	0.000351	0.0014	CcSEcCtD
Nitrazepam—ABCB1—epithelium—ovarian cancer	0.00035	0.0107	CbGeAlD
Nitrazepam—Vision blurred—Doxorubicin—ovarian cancer	0.000349	0.00139	CcSEcCtD
Nitrazepam—ABCB1—uterine cervix—ovarian cancer	0.000347	0.0106	CbGeAlD
Nitrazepam—Asthenia—Docetaxel—ovarian cancer	0.000347	0.00139	CcSEcCtD
Nitrazepam—Convulsion—Epirubicin—ovarian cancer	0.000346	0.00138	CcSEcCtD
Nitrazepam—Pruritus—Docetaxel—ovarian cancer	0.000342	0.00137	CcSEcCtD
Nitrazepam—Agitation—Doxorubicin—ovarian cancer	0.00034	0.00136	CcSEcCtD
Nitrazepam—Anxiety—Epirubicin—ovarian cancer	0.000339	0.00135	CcSEcCtD
Nitrazepam—Nausea—Paclitaxel—ovarian cancer	0.000339	0.00135	CcSEcCtD
Nitrazepam—Malaise—Doxorubicin—ovarian cancer	0.000333	0.00133	CcSEcCtD
Nitrazepam—Vertigo—Doxorubicin—ovarian cancer	0.000332	0.00133	CcSEcCtD
Nitrazepam—Syncope—Doxorubicin—ovarian cancer	0.000332	0.00132	CcSEcCtD
Nitrazepam—Leukopenia—Doxorubicin—ovarian cancer	0.000331	0.00132	CcSEcCtD
Nitrazepam—ABCB1—decidua—ovarian cancer	0.000331	0.0101	CbGeAlD
Nitrazepam—Diarrhoea—Docetaxel—ovarian cancer	0.000331	0.00132	CcSEcCtD
Nitrazepam—Confusional state—Epirubicin—ovarian cancer	0.000329	0.00131	CcSEcCtD
Nitrazepam—Palpitations—Doxorubicin—ovarian cancer	0.000327	0.00131	CcSEcCtD
Nitrazepam—Loss of consciousness—Doxorubicin—ovarian cancer	0.000325	0.0013	CcSEcCtD
Nitrazepam—Infection—Epirubicin—ovarian cancer	0.000324	0.00129	CcSEcCtD
Nitrazepam—Shock—Epirubicin—ovarian cancer	0.000321	0.00128	CcSEcCtD
Nitrazepam—Convulsion—Doxorubicin—ovarian cancer	0.00032	0.00128	CcSEcCtD
Nitrazepam—Dizziness—Docetaxel—ovarian cancer	0.00032	0.00128	CcSEcCtD
Nitrazepam—Hyperhidrosis—Epirubicin—ovarian cancer	0.000315	0.00126	CcSEcCtD
Nitrazepam—ABCB1—endometrium—ovarian cancer	0.000314	0.00956	CbGeAlD
Nitrazepam—Anxiety—Doxorubicin—ovarian cancer	0.000314	0.00125	CcSEcCtD
Nitrazepam—Vomiting—Docetaxel—ovarian cancer	0.000307	0.00123	CcSEcCtD
Nitrazepam—Rash—Docetaxel—ovarian cancer	0.000305	0.00122	CcSEcCtD
Nitrazepam—Hypotension—Epirubicin—ovarian cancer	0.000305	0.00122	CcSEcCtD
Nitrazepam—Dermatitis—Docetaxel—ovarian cancer	0.000305	0.00122	CcSEcCtD
Nitrazepam—Confusional state—Doxorubicin—ovarian cancer	0.000304	0.00122	CcSEcCtD
Nitrazepam—Headache—Docetaxel—ovarian cancer	0.000303	0.00121	CcSEcCtD
Nitrazepam—Infection—Doxorubicin—ovarian cancer	0.0003	0.0012	CcSEcCtD
Nitrazepam—Shock—Doxorubicin—ovarian cancer	0.000297	0.00119	CcSEcCtD
Nitrazepam—Paraesthesia—Epirubicin—ovarian cancer	0.000293	0.00117	CcSEcCtD
Nitrazepam—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000292	0.00117	CcSEcCtD
Nitrazepam—ABCB1—gonad—ovarian cancer	0.000291	0.00887	CbGeAlD
Nitrazepam—Dyspnoea—Epirubicin—ovarian cancer	0.000291	0.00116	CcSEcCtD
Nitrazepam—Somnolence—Epirubicin—ovarian cancer	0.00029	0.00116	CcSEcCtD
Nitrazepam—ABCB1—uterus—ovarian cancer	0.00029	0.00881	CbGeAlD
Nitrazepam—Nausea—Docetaxel—ovarian cancer	0.000287	0.00115	CcSEcCtD
Nitrazepam—Dyspepsia—Epirubicin—ovarian cancer	0.000287	0.00115	CcSEcCtD
Nitrazepam—Hypotension—Doxorubicin—ovarian cancer	0.000282	0.00113	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000282	0.00112	CcSEcCtD
Nitrazepam—Fatigue—Epirubicin—ovarian cancer	0.000281	0.00112	CcSEcCtD
Nitrazepam—Constipation—Epirubicin—ovarian cancer	0.000279	0.00111	CcSEcCtD
Nitrazepam—Paraesthesia—Doxorubicin—ovarian cancer	0.000271	0.00108	CcSEcCtD
Nitrazepam—Dyspnoea—Doxorubicin—ovarian cancer	0.000269	0.00107	CcSEcCtD
Nitrazepam—Feeling abnormal—Epirubicin—ovarian cancer	0.000269	0.00107	CcSEcCtD
Nitrazepam—Somnolence—Doxorubicin—ovarian cancer	0.000268	0.00107	CcSEcCtD
Nitrazepam—Dyspepsia—Doxorubicin—ovarian cancer	0.000266	0.00106	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000261	0.00104	CcSEcCtD
Nitrazepam—ABCB1—female reproductive system—ovarian cancer	0.00026	0.00792	CbGeAlD
Nitrazepam—Fatigue—Doxorubicin—ovarian cancer	0.00026	0.00104	CcSEcCtD
Nitrazepam—Constipation—Doxorubicin—ovarian cancer	0.000258	0.00103	CcSEcCtD
Nitrazepam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000249	0.000994	CcSEcCtD
Nitrazepam—ABCB1—bone marrow—ovarian cancer	0.000246	0.00748	CbGeAlD
Nitrazepam—Hypersensitivity—Epirubicin—ovarian cancer	0.00024	0.00096	CcSEcCtD
Nitrazepam—ABCB1—female gonad—ovarian cancer	0.000237	0.00721	CbGeAlD
Nitrazepam—ABCB1—vagina—ovarian cancer	0.000235	0.00716	CbGeAlD
Nitrazepam—Asthenia—Epirubicin—ovarian cancer	0.000234	0.000935	CcSEcCtD
Nitrazepam—Pruritus—Epirubicin—ovarian cancer	0.000231	0.000922	CcSEcCtD
Nitrazepam—Diarrhoea—Epirubicin—ovarian cancer	0.000223	0.000892	CcSEcCtD
Nitrazepam—Hypersensitivity—Doxorubicin—ovarian cancer	0.000222	0.000888	CcSEcCtD
Nitrazepam—Asthenia—Doxorubicin—ovarian cancer	0.000217	0.000865	CcSEcCtD
Nitrazepam—Dizziness—Epirubicin—ovarian cancer	0.000216	0.000862	CcSEcCtD
Nitrazepam—Pruritus—Doxorubicin—ovarian cancer	0.000214	0.000853	CcSEcCtD
Nitrazepam—ABCB1—testis—ovarian cancer	0.00021	0.00639	CbGeAlD
Nitrazepam—Vomiting—Epirubicin—ovarian cancer	0.000207	0.000828	CcSEcCtD
Nitrazepam—Diarrhoea—Doxorubicin—ovarian cancer	0.000206	0.000825	CcSEcCtD
Nitrazepam—Rash—Epirubicin—ovarian cancer	0.000206	0.000822	CcSEcCtD
Nitrazepam—Dermatitis—Epirubicin—ovarian cancer	0.000205	0.000821	CcSEcCtD
Nitrazepam—Headache—Epirubicin—ovarian cancer	0.000204	0.000816	CcSEcCtD
Nitrazepam—Dizziness—Doxorubicin—ovarian cancer	0.0002	0.000797	CcSEcCtD
Nitrazepam—Nausea—Epirubicin—ovarian cancer	0.000194	0.000774	CcSEcCtD
Nitrazepam—Vomiting—Doxorubicin—ovarian cancer	0.000192	0.000767	CcSEcCtD
Nitrazepam—Rash—Doxorubicin—ovarian cancer	0.00019	0.00076	CcSEcCtD
Nitrazepam—Dermatitis—Doxorubicin—ovarian cancer	0.00019	0.000759	CcSEcCtD
Nitrazepam—Headache—Doxorubicin—ovarian cancer	0.000189	0.000755	CcSEcCtD
Nitrazepam—Nausea—Doxorubicin—ovarian cancer	0.000179	0.000716	CcSEcCtD
Nitrazepam—ABCB1—lymph node—ovarian cancer	0.000152	0.00463	CbGeAlD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.32e-05	0.00153	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.28e-05	0.00152	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MET—ovarian cancer	4.27e-05	0.00152	CbGpPWpGaD
Nitrazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	4.27e-05	0.00151	CbGpPWpGaD
Nitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	4.25e-05	0.00151	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.22e-05	0.00149	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—IL6ST—ovarian cancer	4.19e-05	0.00149	CbGpPWpGaD
Nitrazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.18e-05	0.00148	CbGpPWpGaD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.15e-05	0.00147	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.13e-05	0.00147	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	4.1e-05	0.00146	CbGpPWpGaD
Nitrazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.09e-05	0.00145	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.07e-05	0.00144	CbGpPWpGaD
Nitrazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.03e-05	0.00143	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.99e-05	0.00141	CbGpPWpGaD
Nitrazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.99e-05	0.00141	CbGpPWpGaD
Nitrazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.99e-05	0.00141	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.96e-05	0.00141	CbGpPWpGaD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.96e-05	0.00141	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	3.95e-05	0.0014	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.94e-05	0.0014	CbGpPWpGaD
Nitrazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.91e-05	0.00139	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.85e-05	0.00137	CbGpPWpGaD
Nitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.81e-05	0.00135	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.8e-05	0.00135	CbGpPWpGaD
Nitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.76e-05	0.00133	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—MMP9—ovarian cancer	3.76e-05	0.00133	CbGpPWpGaD
Nitrazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.73e-05	0.00132	CbGpPWpGaD
Nitrazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.73e-05	0.00132	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	3.7e-05	0.00131	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.6e-05	0.00128	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MMP2—ovarian cancer	3.57e-05	0.00126	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.5e-05	0.00124	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.48e-05	0.00123	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	3.45e-05	0.00122	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	3.45e-05	0.00122	CbGpPWpGaD
Nitrazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.44e-05	0.00122	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.44e-05	0.00122	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.38e-05	0.0012	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	3.38e-05	0.0012	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.38e-05	0.0012	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—VEGFA—ovarian cancer	3.37e-05	0.0012	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.35e-05	0.00119	CbGpPWpGaD
Nitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.34e-05	0.00119	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—NRAS—ovarian cancer	3.33e-05	0.00118	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.32e-05	0.00118	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	3.3e-05	0.00117	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.29e-05	0.00117	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	3.29e-05	0.00117	CbGpPWpGaD
Nitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.28e-05	0.00116	CbGpPWpGaD
Nitrazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.28e-05	0.00116	CbGpPWpGaD
Nitrazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.27e-05	0.00116	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.26e-05	0.00116	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.26e-05	0.00116	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.24e-05	0.00115	CbGpPWpGaD
Nitrazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.23e-05	0.00115	CbGpPWpGaD
Nitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.23e-05	0.00114	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.21e-05	0.00114	CbGpPWpGaD
Nitrazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.21e-05	0.00114	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—MAPK3—ovarian cancer	3.19e-05	0.00113	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	3.18e-05	0.00113	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.18e-05	0.00113	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	3.17e-05	0.00112	CbGpPWpGaD
Nitrazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.15e-05	0.00112	CbGpPWpGaD
Nitrazepam—GABRR1—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.14e-05	0.00111	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	3.13e-05	0.00111	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—ERBB2—ovarian cancer	3.12e-05	0.00111	CbGpPWpGaD
Nitrazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.07e-05	0.00109	CbGpPWpGaD
Nitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.06e-05	0.00108	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.04e-05	0.00108	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—MAPK1—ovarian cancer	3.04e-05	0.00108	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—EGFR—ovarian cancer	3.03e-05	0.00108	CbGpPWpGaD
Nitrazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.03e-05	0.00107	CbGpPWpGaD
Nitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.02e-05	0.00107	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3e-05	0.00106	CbGpPWpGaD
Nitrazepam—GABRR1—Neuronal System—MAPK1—ovarian cancer	3e-05	0.00106	CbGpPWpGaD
Nitrazepam—GABRQ—Transmission across Chemical Synapses—HRAS—ovarian cancer	3e-05	0.00106	CbGpPWpGaD
Nitrazepam—GABRR2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3e-05	0.00106	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2.98e-05	0.00106	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—NME2—ovarian cancer	2.97e-05	0.00105	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.88e-05	0.00102	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—KRAS—ovarian cancer	2.87e-05	0.00102	CbGpPWpGaD
Nitrazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.86e-05	0.00102	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.86e-05	0.00102	CbGpPWpGaD
Nitrazepam—GABRR2—Neuronal System—MAPK1—ovarian cancer	2.86e-05	0.00101	CbGpPWpGaD
Nitrazepam—GABRQ—Neuronal System—MAPK1—ovarian cancer	2.86e-05	0.00101	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.86e-05	0.00101	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.86e-05	0.00101	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.85e-05	0.00101	CbGpPWpGaD
Nitrazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.83e-05	0.001	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.8e-05	0.000994	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.8e-05	0.000992	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.78e-05	0.000986	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.77e-05	0.000984	CbGpPWpGaD
Nitrazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.76e-05	0.00098	CbGpPWpGaD
Nitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.75e-05	0.000976	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.75e-05	0.000974	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.74e-05	0.000971	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—CTNNB1—ovarian cancer	2.73e-05	0.000969	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.72e-05	0.000966	CbGpPWpGaD
Nitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.68e-05	0.000952	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MMP9—ovarian cancer	2.68e-05	0.00095	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.67e-05	0.000946	CbGpPWpGaD
Nitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.64e-05	0.000935	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.62e-05	0.000929	CbGpPWpGaD
Nitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.59e-05	0.000919	CbGpPWpGaD
Nitrazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.59e-05	0.000917	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.57e-05	0.000913	CbGpPWpGaD
Nitrazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.57e-05	0.000913	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.56e-05	0.000907	CbGpPWpGaD
Nitrazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.53e-05	0.000896	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	2.52e-05	0.000892	CbGpPWpGaD
Nitrazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.51e-05	0.000891	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.51e-05	0.000891	CbGpPWpGaD
Nitrazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.47e-05	0.000875	CbGpPWpGaD
Nitrazepam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.47e-05	0.000875	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—HRAS—ovarian cancer	2.44e-05	0.000864	CbGpPWpGaD
Nitrazepam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.43e-05	0.000862	CbGpPWpGaD
Nitrazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.43e-05	0.00086	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.42e-05	0.000859	CbGpPWpGaD
Nitrazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.41e-05	0.000854	CbGpPWpGaD
Nitrazepam—GABRR1—Neuronal System—HRAS—ovarian cancer	2.41e-05	0.000853	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—VEGFA—ovarian cancer	2.41e-05	0.000853	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—STAT3—ovarian cancer	2.38e-05	0.000845	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—NRAS—ovarian cancer	2.38e-05	0.000843	CbGpPWpGaD
Nitrazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.37e-05	0.000839	CbGpPWpGaD
Nitrazepam—GABRG3—Neuronal System—MAPK1—ovarian cancer	2.35e-05	0.000835	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—IL6—ovarian cancer	2.33e-05	0.000827	CbGpPWpGaD
Nitrazepam—GABRB1—Neuronal System—MAPK1—ovarian cancer	2.32e-05	0.000823	CbGpPWpGaD
Nitrazepam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.3e-05	0.000816	CbGpPWpGaD
Nitrazepam—GABRR2—Neuronal System—HRAS—ovarian cancer	2.3e-05	0.000814	CbGpPWpGaD
Nitrazepam—GABRQ—Neuronal System—HRAS—ovarian cancer	2.3e-05	0.000814	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MAPK3—ovarian cancer	2.28e-05	0.000807	CbGpPWpGaD
Nitrazepam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.27e-05	0.000805	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.26e-05	0.0008	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—NME2—ovarian cancer	2.23e-05	0.000792	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.23e-05	0.000789	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	2.22e-05	0.000788	CbGpPWpGaD
Nitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.21e-05	0.000783	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.2e-05	0.000779	CbGpPWpGaD
Nitrazepam—GABRA6—Neuronal System—MAPK1—ovarian cancer	2.19e-05	0.000778	CbGpPWpGaD
Nitrazepam—GABRA4—Neuronal System—MAPK1—ovarian cancer	2.17e-05	0.000769	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MAPK1—ovarian cancer	2.17e-05	0.000768	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—EGFR—ovarian cancer	2.17e-05	0.000768	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.16e-05	0.000768	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.12e-05	0.00075	CbGpPWpGaD
Nitrazepam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.08e-05	0.000737	CbGpPWpGaD
Nitrazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.07e-05	0.000733	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—KRAS—ovarian cancer	2.05e-05	0.000725	CbGpPWpGaD
Nitrazepam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.02e-05	0.000716	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2e-05	0.000709	CbGpPWpGaD
Nitrazepam—GABRB2—Neuronal System—MAPK1—ovarian cancer	1.98e-05	0.000703	CbGpPWpGaD
Nitrazepam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.98e-05	0.000703	CbGpPWpGaD
Nitrazepam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.95e-05	0.000691	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.94e-05	0.000687	CbGpPWpGaD
Nitrazepam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.93e-05	0.000686	CbGpPWpGaD
Nitrazepam—GABRA5—Neuronal System—MAPK1—ovarian cancer	1.93e-05	0.000683	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CYTB—ovarian cancer	1.91e-05	0.000678	CbGpPWpGaD
Nitrazepam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.9e-05	0.000674	CbGpPWpGaD
Nitrazepam—GABRA3—Neuronal System—MAPK1—ovarian cancer	1.89e-05	0.000671	CbGpPWpGaD
Nitrazepam—GABRG3—Neuronal System—HRAS—ovarian cancer	1.89e-05	0.00067	CbGpPWpGaD
Nitrazepam—GABRB1—Neuronal System—HRAS—ovarian cancer	1.86e-05	0.00066	CbGpPWpGaD
Nitrazepam—GABRA2—Neuronal System—MAPK1—ovarian cancer	1.86e-05	0.000659	CbGpPWpGaD
Nitrazepam—GABRB3—Neuronal System—MAPK1—ovarian cancer	1.85e-05	0.000655	CbGpPWpGaD
Nitrazepam—GABRG2—Neuronal System—MAPK1—ovarian cancer	1.81e-05	0.000643	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.79e-05	0.000633	CbGpPWpGaD
Nitrazepam—GABRA6—Neuronal System—HRAS—ovarian cancer	1.76e-05	0.000625	CbGpPWpGaD
Nitrazepam—GABRA4—Neuronal System—HRAS—ovarian cancer	1.74e-05	0.000617	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—HRAS—ovarian cancer	1.74e-05	0.000617	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PPP1CC—ovarian cancer	1.67e-05	0.000592	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—BRIP1—ovarian cancer	1.67e-05	0.000592	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—IL6—ovarian cancer	1.66e-05	0.00059	CbGpPWpGaD
Nitrazepam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.66e-05	0.000589	CbGpPWpGaD
Nitrazepam—GABRB2—Neuronal System—HRAS—ovarian cancer	1.59e-05	0.000564	CbGpPWpGaD
Nitrazepam—GABRA1—Neuronal System—MAPK1—ovarian cancer	1.58e-05	0.000562	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.55e-05	0.000551	CbGpPWpGaD
Nitrazepam—GABRA5—Neuronal System—HRAS—ovarian cancer	1.55e-05	0.000548	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—AKT1—ovarian cancer	1.54e-05	0.000544	CbGpPWpGaD
Nitrazepam—GABRA3—Neuronal System—HRAS—ovarian cancer	1.52e-05	0.000538	CbGpPWpGaD
Nitrazepam—GABRA2—Neuronal System—HRAS—ovarian cancer	1.49e-05	0.000529	CbGpPWpGaD
Nitrazepam—GABRB3—Neuronal System—HRAS—ovarian cancer	1.48e-05	0.000526	CbGpPWpGaD
Nitrazepam—GABRG2—Neuronal System—HRAS—ovarian cancer	1.46e-05	0.000516	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.44e-05	0.000512	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CYTB—ovarian cancer	1.44e-05	0.00051	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.44e-05	0.00051	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.41e-05	0.0005	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.39e-05	0.000495	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—NME2—ovarian cancer	1.38e-05	0.000488	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.37e-05	0.000486	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.36e-05	0.000482	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.32e-05	0.000469	CbGpPWpGaD
Nitrazepam—GABRA1—Neuronal System—HRAS—ovarian cancer	1.27e-05	0.000451	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.26e-05	0.000446	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—BRIP1—ovarian cancer	1.26e-05	0.000446	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.2e-05	0.000424	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.13e-05	0.000401	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—YAP1—ovarian cancer	1.12e-05	0.000397	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.1e-05	0.00039	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.08e-05	0.000382	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.08e-05	0.000382	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.02e-05	0.00036	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.34e-06	0.000331	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—FASN—ovarian cancer	9.13e-06	0.000324	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.03e-06	0.00032	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—SLC5A5—ovarian cancer	8.98e-06	0.000319	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CYTB—ovarian cancer	8.87e-06	0.000314	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—SLC2A1—ovarian cancer	8.68e-06	0.000308	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—YAP1—ovarian cancer	8.44e-06	0.000299	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CYP1B1—ovarian cancer	8.32e-06	0.000295	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.75e-06	0.000275	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.75e-06	0.000275	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.63e-06	0.000271	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	7.38e-06	0.000262	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—FASN—ovarian cancer	6.88e-06	0.000244	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—ABCB1—ovarian cancer	6.85e-06	0.000243	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.76e-06	0.00024	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—TYMS—ovarian cancer	6.73e-06	0.000239	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.53e-06	0.000232	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.26e-06	0.000222	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.55e-06	0.000197	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CAV1—ovarian cancer	5.42e-06	0.000192	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—YAP1—ovarian cancer	5.2e-06	0.000184	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—TYMS—ovarian cancer	5.07e-06	0.00018	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PIK3CG—ovarian cancer	4.94e-06	0.000175	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PIK3CD—ovarian cancer	4.34e-06	0.000154	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—FASN—ovarian cancer	4.24e-06	0.00015	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.17e-06	0.000148	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CAV1—ovarian cancer	4.08e-06	0.000145	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.02e-06	0.000143	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.86e-06	0.000137	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PIK3CB—ovarian cancer	3.78e-06	0.000134	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.72e-06	0.000132	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.42e-06	0.000121	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PTEN—ovarian cancer	3.27e-06	0.000116	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.27e-06	0.000116	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.18e-06	0.000113	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—TYMS—ovarian cancer	3.12e-06	0.000111	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.85e-06	0.000101	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CAV1—ovarian cancer	2.51e-06	8.92e-05	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PTEN—ovarian cancer	2.46e-06	8.73e-05	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.31e-06	8.18e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.29e-06	8.12e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.01e-06	7.14e-05	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—AKT1—ovarian cancer	1.88e-06	6.68e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.76e-06	6.22e-05	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.74e-06	6.16e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PTEN—ovarian cancer	1.52e-06	5.38e-05	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—AKT1—ovarian cancer	1.42e-06	5.03e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.07e-06	3.79e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—AKT1—ovarian cancer	8.74e-07	3.1e-05	CbGpPWpGaD
